⌘K

Login Start Free

Home/Filings/4/0002001011-25-000048

4//SEC Filing

Reardon Andrew 4

Accession 0002001011-25-000048

CIK 0000886163other

View on SEC.gov Company Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 8:29 PM ET

Size

4.4 KB

Accession

0002001011-25-000048

Insider Transaction Report

Form 4

Period: 2025-06-23

LIGAND PHARMACEUTICALS INCLGND

CLO & Secretary

Transactions

Sale
Common Stock
2025-06-23$114.08/sh−500$57,042→ 31,903 total

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1

filerCIK 0001950232

Filing Metadata

Form type: 4
Filed: Jun 23, 8:00 PM ET
Accepted: Jun 24, 8:29 PM ET
Size: 4.4 KB

View on SEC.gov